

REVIEW ARTICLE Year : 2015 | Volume : 19 | Issue : 2 | Page : 198-203

Fasts, feasts and festivals in diabetes-1: Glycemic management during Hindu fasts



Sanjay Kalra1, Sarita Bajaj2, Yashdeep Gupta3, Pankaj Agarwal4, SK Singh5, Sandeep Julka6, Rajeev Chawla7, Navneet Agrawal8

1 Department of Endocrinology, Bharti Hospital and Bride, Karnal, Haryana, India

2 Department of Medicine, MLN Medical College, Allahabad, India

3 Department of Medicine, Governemnt Medical College, Chandigarh, India

4 Department of Endocrinology, Hormone Care and Research Centre, Ghaziabad, India

5 Department of Endocrinology, Banaras Hindu University, Varanasi, Uttar Pradesh, India

6 Department of Endocrinology, Synergy Hospital, Indore, Madhya Pradesh, India

7 Department of Medicine, North Delhi Diabetes Centre, New Delhi, India

8 Department of Medicine, Diabetes, Obesity and Thyroid Clinic, Gwalior, Madhya Pradesh, India



Date of Web Publication 14-Jan-2015

Correspondence Address:

Sanjay Kalra

Department of Endocrinology, Bharti Hospital and BRIDE, Karnal, Haryana

India

Source of Support: None, Conflict of Interest: None Check 10

DOI: 10.4103/2230-8210.149314



Abstract

This communication is the first of a series on South Asian fasts, festivals, and diabetes, designed to spread awareness and stimulate research on this aspect of diabetes and metabolic care. It describes the various fasts observed as part of Hindu religion and offers a classification scheme for them, labeling them as infrequent and frequent. The infrequent fasts are further sub-classified as brief and prolonged, to facilitate a scientific approach to glycemic management during these fasts. Pre-fast counseling, non-pharmacological therapy, pharmacological modification, and post-fast debriefing are discussed in detail. All available drug classes and molecules are covered in this article, which provides guidance about necessary changes in dosage and timing of administration. While in no way exhaustive, the brief review offers a basic framework which diabetes care professionals can use to counsel and manage persons in their care who wish to observe various Hindu fasts.

Keywords: Culture bound medicine, diabetes mellitus, Hinduism, India, insulin, oral hypoglycemic agents

How to cite this article:

Kalra S, Bajaj S, Gupta Y, Agarwal P, Singh S K, Julka S, Chawla R, Agrawal N. Fasts, feasts and festivals in diabetes-1: Glycemic management during Hindu fasts. Indian J Endocr Metab 2015;19:198-203

How to cite this URL:

Kalra S, Bajaj S, Gupta Y, Agarwal P, Singh S K, Julka S, Chawla R, Agrawal N. Fasts, feasts and festivals in diabetes-1: Glycemic management during Hindu fasts. Indian J Endocr Metab [serial online] 2015 [cited 2020 Sep 20];19:198-203. Available from: http://www.ijem.in/text.asp?2015/19/2/198/149314

Introduction

Hindu Fasts

Non-Pharmacological Therapy

Approach to Modification of Pharmacological Therapy During Fasting

Table 1: Factors influencing approach to glucose lowering drug treatment during fasting



Click here to view

Post-Fast Debriefing

Infrequent but Brief Fasts

Table 2: Modifi cation of glucose-lowering therapy during Karva Chauth



Click here to view

Infrequent but Prolonged Fasts

Frequent Fasts

Table 3: Modifi cation of glucose-lowering therapy in persons who fast frequently



Click here to view

Discussion

Conclusion

References

1.

Latt TS, Baruah MP, Sahay R. Nutritional recommendations for type 2 diabetes during Buddhist Lent (War Dwin). J Med Nutr Nutraceutical 2013;2:84-5. 2.

Jaleel MA, Raza SA, Fathima FN, Jaleel BN. Ramadan and diabetes: As-Saum (The fasting). Indian J Endocrinol Metab 2011;15:268-73. 3.

Hinduism. Available from: http://www.en.wikipedia.org/wiki/Hinduism. [Last accessed on 2014 Dec 08]. 4.

Kelwade J, Sethi BK, Vaseem A, Nagesh VS. Sodium glucose co transporter 2 inhibitors and Ramadan: Another string to the bow. Indian J Endocrinol Metab 2014;18:874-5. 5.

Fatima J, Karoli R, Chandra A, Naqvi N. Ramadan fasting in patients with type 2 diabetes mellitus: Experience from a teaching hospital. Indian J Endocrinol Metab 2012;16:323-4. 6.

Jaleel MA, Fathima FN, Jaleel BN. Nutrition, energy intake-output, exercise, and fluid homeostasis during fasting in Ramadan. J Med Nutr Nutraceutical 2013;2:63-8. 7. et al. Role of oral hypoglycemic agents in the management of type 2 diabetes mellitus during Ramadan. Indian J Endocrinol Metab 2012;16:503-7.

Bashir MI, Pathan MF, Raza SA, Ahmad J, Khan AK, Ishtiaq O,. Role of oral hypoglycemic agents in the management of type 2 diabetes mellitus during Ramadan. Indian J Endocrinol Metab 2012;16:503-7. 8. et al. Management of type 2 diabetes in Ramadan: Low-ratio premix insulin working group practical advice. Indian J Endocrinol Metab 2014;18:794-9.

Hassanein M, Belhadj M, Abdallah K, Bhattacharya AD, Singh AK, Tayeb K,. Management of type 2 diabetes in Ramadan: Low-ratio premix insulin working group practical advice. Indian J Endocrinol Metab 2014;18:794-9. 9. et al. South Asian Consensus Guideline: Use of GLP-1 analogue therapy in diabetes during Ramadan. Indian J Endocrinol Metab 2012;16:525-7.

Pathan MF, Sahay RK, Zargar AH, Raza SA, Khan AK, Siddiqui NI,. South Asian Consensus Guideline: Use of GLP-1 analogue therapy in diabetes during Ramadan. Indian J Endocrinol Metab 2012;16:525-7.

Tables